LOKON PHARMA is a Swedish biotech company in the forefront of developing immunostimulatory gene therapy for cancer-based on oncolytic viruses. Innovative gene engineering, solid expertise in cancer biology and immunology, as well as a genuine curiosity in life science expand Lokon’s pipeline towards groundbreaking new therapeutics for patients with high unmet medical need.
Company Details
- Employees
- 14
- Founded
- 2011
- Address
- Uppsala, Uppsala County
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://lokonpharma.com
- Keywords
- Immunotherapy, Gene therapy, ATMP, Oncology.
- HQ
- Uppsala, Uppsala County
Lokon Pharma Ab Questions
Lokon Pharma Ab's website is http://lokonpharma.com
Lokon Pharma Ab's LinkedIn profile is https://se.linkedin.com/company/lokon-pharma-ab
Lokon Pharma Ab has
14 employees.
View email and phone details for 14
employees at Lokon Pharma Ab.
Lokon Pharma Ab's industry is
Pharmaceutical Manufacturing
Lokon Pharma Ab's top competitors are
Bioxl Ltd,
Complyit Ab,
Ilya Pharma,
Elicera Therapeutics Ab,
Alx Oncology,
Neogap Therapeutics Ab,
Rarity Bioscience,
Strike Pharma Ab,
Zozium,
Medivir Ab.
Lokon Pharma Ab's categories are Pharmaceutical Manufacturing
Lokon Pharma Ab's founding year is 2011
